Aytu BioScience Inc. (NASDAQ: AYTU) is 42.93% higher on its value in year-to-date trading and has touched a low of $0.34 and a high of $2.99 in the current 52-week trading range. The AYTU stock was last observed hovering at around $1.39 in the last trading session, with the day’s loss setting it -0.08% off its average median price target of $2.75 for the next 12 months. It is also 56.33% off the consensus price target high of $3.00 offered by 2 analysts, but current levels are 47.6% higher than the price target low of $2.50 for the same period.
Gold bugs are shouting from the rooftops in excitement, but that doesn’t mean you rush out and just buy any gold stock…That’s why we laid out The 2021 Ultimate Gold Portfolio – to dissect the treasure from the trash.
Currently trading at $1.31, the stock is -5.30% and -7.36% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.52 million and changing -5.76% at the moment leaves the stock 10.37% off its SMA200. AYTU registered 4.51% gain for a year compared to 6-month gain of 76.02%. The firm has a 50-day simple moving average (SMA 50) of $1.3809 and a 200-day simple moving average (SMA200) of $1.3309.
The stock witnessed a 0.72% loss in the last 1 month and extending the period to 3 months gives it a -10.32%, and is 1.09% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.10% over the week and 4.82% over the month.
Aytu BioScience Inc. (AYTU) has around 53 employees, a market worth around $167.12M and $14.50M in sales. Distance from 52-week low is 290.81% and -56.19% from its 52-week high.
Aytu BioScience Inc. (AYTU) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Aytu BioScience Inc. (AYTU) is a “Buy”. 2 analysts offering their recommendations for the stock have an average rating of 1.50, where 0 rate it as a Hold and 0 think it is a “Overweight”. 2 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Aytu BioScience Inc. quarterly earnings per share for the current quarter are estimated at -$0.03 with sales reaching $11.24M over the same period.The EPS is expected to grow by 77.30% this year, but quarterly earnings will post 228.10% year-over-year. Quarterly sales are estimated to grow 555.40% in year-over-year returns.
Aytu BioScience Inc. (AYTU) Top Institutional Holders
29 institutions hold shares in Aytu BioScience Inc. (AYTU), with 7.5M shares held by insiders accounting for 6.24% while institutional investors hold 12.81% of the company’s shares. The shares outstanding are 120.62M, and float is at 116.08M with Short Float at 6.50%. Institutions hold 12.01% of the Float.
Aytu BioScience Inc. (AYTU) Insider Activity
A total of 11 insider transactions have happened at Aytu BioScience Inc. (AYTU) in the last six months, with sales accounting for 3 and purchases happening 8 times.